Prenatal alcohol exposure may make the brain more inflamed after morphine
Prenatal alcohol exposure generates vulnerability to the proinflammatory effects of morphine and adverse neuroimmune consequences
This work tests whether adults who were exposed to alcohol before birth have stronger brain immune reactions when given morphine pain medicine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of New Mexico Health Scis Ctr NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project ID | NIH-11329977 on NIH RePORTER |
What this research studies
Researchers use animal models that were exposed to alcohol before birth to mirror Fetal Alcohol Spectrum Disorders and then give morphine to see how the nervous system responds. They measure inflammatory signals such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) and examine activation of spinal astrocytes and immune cells. The team studies molecular pathways including TLR4 and the NLRP3 inflammasome to understand why pain sensitivity and pathological pain might increase. Findings are meant to explain risks seen in adults with prenatal alcohol exposure and point toward safer pain treatment approaches.
Who could benefit from this research
Good fit: Adults with a diagnosis of Fetal Alcohol Spectrum Disorders or a known history of prenatal alcohol exposure, particularly those who may need opioid pain treatment, would be the most relevant candidates.
Not a fit: People without prenatal alcohol exposure and children under 21 are unlikely to directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could help identify people with prenatal alcohol exposure who are at higher risk for opioid-related brain inflammation and guide safer pain treatment choices.
How similar studies have performed: Previous animal studies have shown that prenatal alcohol exposure raises central inflammatory signals and that morphine can activate TLR4, but combining these pathways to explain opioid harms in FASD is a newer approach.
Where this research is happening
Albuquerque, United States
- University of New Mexico Health Scis Ctr — Albuquerque, United States (Active)
Researchers
- Principal investigator: Noor, Shahani — University of New Mexico Health Scis Ctr
- Study coordinator: Noor, Shahani
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.